Thursday, May 24, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Drug Discovery & Development
Profiling the profilers
In the last edition of NGP, Jeffrey Till gave us a brief insight into the role of kinase profiling in drug development. We caught up with Jeff to find out more.
No Comments
The hard cell: Genomics and the future of drug discovery
By Dr Christopher Austin, Senior Advisor to the Director for Translational Research and Director of the National Institutes of Health (NIH) Chemical Genomics Center, National Human Genome Research Institute.
No Comments
Target Acquired
Ambion's David Dorris and Qiagen's Walter Tian on how to exploit the benefits of RNAi.
No Comments
Gene Genies
Jay Flatley, Illumina, and Doug Amorese, Agilent, go head-to-head on one of pharma's hottest topics.
No Comments
Banking on IT
New technology needs new rules to be most effective. Brock Reeve talks biobanks.
No Comments
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.